Regulatory Intelligence · Based on 5,975 enriched FDA records

FDA 510(k) Consultants – Regulatory Consulting Firms Directory

Regulatory consulting firms identified across 5,975 FDA 510(k) submissions where per-record enrichment was available, ranked by submission volume. Data extracted from the correspondent field of individual 510(k) records on FDA accessdata.gov - this field is not included in the FDA bulk downloadable files and requires per-record extraction.

This is not a curated listing or marketing directory. It is a data-driven ranking of FDA 510(k) regulatory consulting activity based on real submission records from FDA accessdata.gov, enabling objective comparison of consulting firm involvement in medical device clearances.

  • Compare regulatory consulting firms by FDA 510(k) submission activity
  • Identify experienced 510(k) consultants by real clearance data
  • Filter by FDA review panel and medical device specialty

Used by regulatory affairs teams and medical device manufacturers to benchmark FDA 510(k) submission activity and consultant involvement.

1,182
Consulting firms
5,975
Managed submissions

Methodology: A regulatory consultant is identified when the correspondent field of a 510(k) submission differs from the applicant (device manufacturer). This covers regulatory affairs firms, contract regulatory organizations (CROs), and authorized representatives. Only firms with 3 or more submissions are listed. Some entries may represent authorized representatives rather than independent consulting firms.

This dataset is widely used to benchmark regulatory consulting activity in the medical device industry.

Data last updated: May 25, 2026

Most Active FDA 510(k) Regulatory Consulting Firms

383 firms identified across 510(k) submissions managed on behalf of medical device manufacturers. Ranked by total submission volume. · Updated May 2026.

383 firms
1–50 of 383
# Firm Submissions Cleared Active panels Active since
1 228 100% 2021 -2026
2 222 100% 2020 -2026
3 199 100% 2021 -2026
4 131 100% 2021 -2026
5 114 100% 2021 -2026
6 113 100% 2021 -2026
7 108 100% 2021 -2024
8 108 100% 2021 -2024
9 91 100% 2021 -2026
10 77 100% 2021 -2026
11 76 100% 2021 -2026
12 74 100% 2021 -2026
13 73 100% 2021 -2026
14 69 100% 2021 -2026
15 69 100% 2022 -2026
16 61 100% 2015 -2026
17 54 100% 2021 -2026
18 50 100% 2021 -2026
19 48 100% 2022 -2026
20 48 100% 2021 -2026
21 41 100% 2021 -2025
22 39 100% 2021 -2026
23 39 100% 2021 -2026
24 35 100% 2021 -2025
25 35 100% 2021 -2026
26 34 100% 2021 -2023
27 33 100% 2021 -2026
28 33 100% 2021 -2026
29 32 100% 2021 -2026
30 32 100% 2022 -2025
31 31 100% 2021 -2026
32 30 100% 2021 -2026
33 30 100% 2021 -2025
34 30 100% 2021 -2026
35 30 100% 2021 -2026
36 29 100% 2021 -2025
37 28 100% 2021 -2026
38 27 100% 2021 -2025
39 26 100% 2021 -2025
40 24 100% 2021 -2026
41 23 100% 2021 -2026
42 23 100% 2021 -2025
43 22 100% 2021 -2025
44 22 100% 2021 -2026
45 21 100% 2021 -2024
46 21 100% 2021 -2026
47 21 100% 2021 -2025
48 21 100% 2021 -2026
49 21 100% 2016 -2025
50 20 100% 2021 -2026

About Regulatory Consultants in FDA 510(k) Submissions

Why Manufacturers Use Regulatory Consultants

Medical device manufacturers - particularly startups and international companies - frequently engage regulatory consulting firms to prepare and manage their 510(k) premarket notifications. Consultants bring expertise in predicate device selection, substantial equivalence argumentation, and FDA reviewer communications.

Of the 5,975 submissions in the 510k Database dataset where a consultant is identified, three of the ten most active firms are China-based - reflecting the volume of Chinese manufacturers seeking FDA market access.

Data Source and Methodology

Consultant identification is based on the correspondent field extracted from individual 510(k) submission pages on FDA accessdata.fda.gov. This field is not included in the FDA downloadable flat files - it requires per-record enrichment. The 510k Database processes this enrichment as part of its data pipeline. Dataset published on Zenodo (DOI: 10.5281/zenodo.20269611).